UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 182

Sortiert nach

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Oncogene, 2003-10, Vol.22 (47), p.7265-7279

Siddik, Zahid H

2003

Link zum Volltext

Verfügbarkeit prüfen

Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations

Journal of nanoparticle research : an interdisciplinary forum for nanoscale science and technology, 2020-06, Vol.22 (6), Article 141

2020

Link zum Volltext

Verfügbarkeit prüfen

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53

Biochemical pharmacology, 2012-04, Vol.83 (8), p.1049-1062

2012

Link zum Volltext

Verfügbarkeit prüfen

Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents

Proceedings of the National Academy of Sciences - PNAS, 2020-03, Vol.117 (13), p.7021-7029

2020

Link zum Volltext

Verfügbarkeit prüfen

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Clinical cancer research, 2021-01, Vol.27 (2), p.542-553

2021

Link zum Volltext

Verfügbarkeit prüfen

Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2012-09, Vol.30 (27), p.3345-3352

2012

Link zum Volltext

Verfügbarkeit prüfen

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2014-07, Vol.85 (1), p.88-93

2014

Link zum Volltext

Verfügbarkeit prüfen

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (17), p.8240-8247

2007

Link zum Volltext

Verfügbarkeit prüfen

Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities

Oncogene, 2005-04, Vol.24 (18), p.2929-2943

2005

Link zum Volltext

Verfügbarkeit prüfen

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

The Journal of biological chemistry, 2003-05, Vol.278 (21), p.19245-19256

2003

Link zum Volltext

Verfügbarkeit prüfen

Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape

Cell biochemistry and function, 2015-07, Vol.33 (5), p.257-265

2015

Link zum Volltext

Verfügbarkeit prüfen

Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma

Neoplasia (New York, N.Y.), 2013-05, Vol.15 (5), p.502-IN15

2013

Link zum Volltext

Verfügbarkeit prüfen

Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights

Seminars in cancer biology, 2019-10, Vol.58, p.65-79

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells

Molecular cancer therapeutics, 2004-12, Vol.3 (12), p.1543-1549

2004

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill

Molecular pharmacology, 2020-04, Vol.97 (4), p.237-249

2020

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Clinical cancer research, 2009-06, Vol.15 (11), p.3770-3780

2009

Link zum Volltext

Verfügbarkeit prüfen

Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

Frontiers in pharmacology, 2017-12, Vol.8, p.871-871

2017

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]

EBioMedicine, 2022-09, Vol.83, p.104194-104194, Article 104194

2022

Link zum Volltext

Verfügbarkeit prüfen

Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1

Molecular pharmacology, 2008-09, Vol.74 (3), p.697-704

2008

Link zum Volltext

Verfügbarkeit prüfen

Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator

Angewandte Chemie (International ed.), 2016-10, Vol.55 (41), p.12626-12631

International ed. in English, 2016

Link zum Volltext

Verfügbarkeit prüfen

Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents

Cancer chemotherapy and pharmacology, 2020-06, Vol.85 (6), p.1129-1140

2020

Link zum Volltext

Verfügbarkeit prüfen

Recent Developments in Texaphyrin Chemistry and Drug Discovery

Inorganic chemistry, 2013-11, Vol.52 (21), p.12184-12192

2013

Link zum Volltext

Verfügbarkeit prüfen

Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner

Cancer chemotherapy and pharmacology, 2010-02, Vol.65 (3), p.427-436

2010

Link zum Volltext

Verfügbarkeit prüfen

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status

Oncotarget, 2017-01, Vol.8 (1), p.490-505

2017

Link zum Volltext

Verfügbarkeit prüfen

Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation

Molecular cancer research, 2017-03, Vol.15 (3), p.328-339

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 182

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(177)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(93)
Animals
(60)
Biological And Medical Sciences
(60)
Humans
(60)
Medical Sciences
(56)
Oncology
(53)
Pharmacology. Drug Treatments
(48)
Female
(46)
Antineoplastic Agents
(44)
Antineoplastic Agents - Pharmacology
(32)
Male
(31)
Mice
(30)
Pharmacology & Pharmacy
(29)
Cisplatin - Pharmacology
(27)
Tumor Cells, Cultured
(27)
Chemistry
(24)
General Aspects
(24)
Platinum
(21)
Drug Resistance, Neoplasm
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations

Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53

Oxaliplatin Pt(IV) prodrugs conjugated to gadolinium-texaphyrin as potential antitumor agents

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer

Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer

Epidermal growth factor receptor (EGFR) ubiquitination as a mechanism of acquired resistance escaping treatment by the anti-EGFR monoclonal antibody cetuximab

Induction of p21 by p53 following DNA damage inhibits both Cdk4 and Cdk2 activities

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape

Biologic Effects of Dopamine on Tumor Vasculature in Ovarian Carcinoma

Overview of the oncogenic signaling pathways in colorectal cancer: Mechanistic insights

Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells

Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill

Therapeutic Targeting of ATP7B in Ovarian Carcinoma

Curcumin-Free Turmeric Exhibits Activity against Human HCT-116 Colon Tumor Xenograft: Comparison with Curcumin and Whole Turmeric

Corrigendum to “PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis” [EBioMedicine 40 (2019) 290-304]

Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1

Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator

Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents

Recent Developments in Texaphyrin Chemistry and Drug Discovery

Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner

New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status

Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation

Suchergebnisse filtern